FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102133058> ?p ?o ?g. }

• W2102133058 endingPage "30" @default.
• W2102133058 startingPage "20" @default.
• W2102133058 abstract "Type 1 diabetes (T1D) is an autoimmune disease that results from a deficient induction or maintenance of tolerance to islet β-cell antigens, allowing the eventual T-cell–mediated destruction of insulin-producing β-cells within the pancreatic islets (1). Under homeostatic conditions, immune tolerance is established by various subsets of antigen-presenting cells (APCs) with tolerance-inducing/maintaining (tolerogenic) functions and reinforced by other cells with suppressor and immunomodulatory properties. T-cell tolerance manifests itself through elimination (deletion), inactivation (anergy), or suppression of self-reactive T cells (Fig. 1 A ). These functions may be performed by a variety of tolerogenic APCs (Table 1), some of which have the ability to induce/boost regulatory T cells (Tregs) and/or B cells (Bregs). Genetic and environmental factors that vary among different individuals contribute to the development of T1D, in part by impacting mechanisms of tolerance (Fig. 1 B ). Therefore, a major goal for the prevention and/or reversal of T1D is to restore effective and durable tolerance to either prevent further destruction of remaining islet β-cells, help islet β-cell regeneration, or protect islet transplants and obviate the use of nonspecific immunosuppressive drugs. The approach reviewed here consists of developing a personalized therapy using the patient’s own cells manipulated to perform as tolerogenic APCs (Fig. 1 C ). In this review, we will explain why dendritic cells (DCs) are the tolerogenic cells of choice to fulfill the goal of restoring immune tolerance in T1D as part of a potentially powerful and safe cellular immunotherapy, the next generation of therapies (2). We will present the clinical considerations and challenges ahead and the plans to address them, taking into account lessons learned from animal models such as the NOD mouse.Figure 1 Tolerance to β-cell antigens: induction, loss, and restoration. A : Tolerance to β-cell antigens is induced and maintained by tolerogenic cells comprised of migratory DCs transporting antigens from peripheral to lymphoid …" @default.
• W2102133058 created "2016-06-24" @default.
• W2102133058 creator A5001857296 @default.
• W2102133058 creator A5016211633 @default.
• W2102133058 creator A5017682705 @default.
• W2102133058 creator A5063861097 @default.
• W2102133058 creator A5081113197 @default.
• W2102133058 date "2013-12-13" @default.
• W2102133058 modified "2023-10-18" @default.
• W2102133058 title "It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes" @default.
• W2102133058 cites W1492703726 @default.
• W2102133058 cites W1502510454 @default.
• W2102133058 cites W1506579269 @default.
• W2102133058 cites W1545313141 @default.
• W2102133058 cites W1858305708 @default.
• W2102133058 cites W1917759414 @default.
• W2102133058 cites W1963555903 @default.
• W2102133058 cites W1971666638 @default.
• W2102133058 cites W1983279004 @default.
• W2102133058 cites W1984014273 @default.
• W2102133058 cites W1994437064 @default.
• W2102133058 cites W1996532235 @default.
• W2102133058 cites W1997112242 @default.
• W2102133058 cites W2009446037 @default.
• W2102133058 cites W2010648161 @default.
• W2102133058 cites W2014601653 @default.
• W2102133058 cites W2023497353 @default.
• W2102133058 cites W2026471664 @default.
• W2102133058 cites W2028371096 @default.
• W2102133058 cites W2029639421 @default.
• W2102133058 cites W2031450658 @default.
• W2102133058 cites W2034402052 @default.
• W2102133058 cites W2034681068 @default.
• W2102133058 cites W2037997647 @default.
• W2102133058 cites W2047768051 @default.
• W2102133058 cites W2050216284 @default.
• W2102133058 cites W2056404718 @default.
• W2102133058 cites W2056628849 @default.
• W2102133058 cites W2058799877 @default.
• W2102133058 cites W2063917748 @default.
• W2102133058 cites W2065058582 @default.
• W2102133058 cites W2069715509 @default.
• W2102133058 cites W2071872606 @default.
• W2102133058 cites W2073694191 @default.
• W2102133058 cites W2081461736 @default.
• W2102133058 cites W2081522241 @default.
• W2102133058 cites W2082591904 @default.
• W2102133058 cites W2088992114 @default.
• W2102133058 cites W2089408155 @default.
• W2102133058 cites W2090676538 @default.
• W2102133058 cites W2091855459 @default.
• W2102133058 cites W2096385412 @default.
• W2102133058 cites W2102689053 @default.
• W2102133058 cites W2109280271 @default.
• W2102133058 cites W2111740348 @default.
• W2102133058 cites W2117477752 @default.
• W2102133058 cites W2122400330 @default.
• W2102133058 cites W2125659714 @default.
• W2102133058 cites W2126747080 @default.
• W2102133058 cites W2131208717 @default.
• W2102133058 cites W2132051812 @default.
• W2102133058 cites W2132076942 @default.
• W2102133058 cites W2132502360 @default.
• W2102133058 cites W2139771438 @default.
• W2102133058 cites W2144177716 @default.
• W2102133058 cites W2144276100 @default.
• W2102133058 cites W2145193656 @default.
• W2102133058 cites W2149710269 @default.
• W2102133058 cites W2164514549 @default.
• W2102133058 cites W2324766944 @default.
• W2102133058 doi "https://doi.org/10.2337/db13-0886" @default.
• W2102133058 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3968436" @default.
• W2102133058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24357690" @default.
• W2102133058 hasPublicationYear "2013" @default.
• W2102133058 type Work @default.
• W2102133058 sameAs 2102133058 @default.
• W2102133058 citedByCount "47" @default.
• W2102133058 countsByYear W21021330582014 @default.
• W2102133058 countsByYear W21021330582015 @default.
• W2102133058 countsByYear W21021330582016 @default.
• W2102133058 countsByYear W21021330582017 @default.
• W2102133058 countsByYear W21021330582018 @default.
• W2102133058 countsByYear W21021330582019 @default.
• W2102133058 countsByYear W21021330582020 @default.
• W2102133058 countsByYear W21021330582021 @default.
• W2102133058 countsByYear W21021330582022 @default.
• W2102133058 countsByYear W21021330582023 @default.
• W2102133058 crossrefType "journal-article" @default.
• W2102133058 hasAuthorship W2102133058A5001857296 @default.
• W2102133058 hasAuthorship W2102133058A5016211633 @default.
• W2102133058 hasAuthorship W2102133058A5017682705 @default.
• W2102133058 hasAuthorship W2102133058A5063861097 @default.
• W2102133058 hasAuthorship W2102133058A5081113197 @default.
• W2102133058 hasBestOaLocation W21021330581 @default.
• W2102133058 hasConcept C126322002 @default.
• W2102133058 hasConcept C134018914 @default.
• W2102133058 hasConcept C18903297 @default.
• W2102133058 hasConcept C2777180221 @default.

• next